Scott

Introduction

  • Speaker: Scott Hines
  • Objective: To present a different perspective on the pharmacy industry and career paths in this field.
  • Emphasis on an interactive, discussion-oriented format rather than a one-way lecture.

Background

  • Education:
      - Obtained PharmD from the University of Iowa in 2000.
      - Furthered education with a PhD in pharmaceutical sciences from the University of Michigan.
      - Specialized in pharmacokinetics and pharmacodynamics (PK/PD).
  • Career Path:
      - Postdoctoral fellowship at the University of Arizona.
      - Career began at Eli Lilly Company in 2006, working in clinical pharmacology, global PKPD, and pharmacometrics for over 15 years.
      - Transitioned to a smaller biotech company to establish and lead a clinical pharmacology group, marking a significant career change.
      - Experienced multiple company acquisitions that led to further opportunities in small pharma biotech companies over the last five years.

Clinical Pharmacology Overview

Definition:
  • Clinical pharmacology is the study of drug disposition and pharmacological effect in humans.
  • Integrates data from multiple disciplines:
      - Pharmacology
      - Toxicology
      - Medicinal Chemistry
      - Physiology
      - Clinical Safety
      - Clinical Ethics
Goals:
  • Understand how a drug is processed by the body and its effect on efficacy and safety.
  • Evaluate the benefit-risk profile of drugs during regulatory approvals.
  • Aim for optimal drug utilization through dose optimization for diverse patient populations.
Importance in Drug Development:
  • Engages in every phase of the drug development process.
  • Addresses the quantification of the relationship between drug dose and its effects on safety and efficacy.

Pharmacokinetics vs. Pharmacodynamics

Pharmacokinetics (PK):
  • Study of how the body affects a drug:
      - Absorption
      - Distribution
      - Metabolism
      - Excretion (ADME)
  • PK and plasma concentration correlations are evaluated to inform dosing regimens.
Pharmacodynamics (PD):
  • Study of the effects of the drug on the body.
  • Understanding the desired response and potential side effects.
  • Integral in evaluating drug effectiveness and safety.
PK/PD Relationship:
  • Characterizes the temporal relationship between drug exposure and therapeutic effects.
  • Determines the therapeutic index (TI): a measure of the safety profile of a drug, defined by the difference between effective doses and the onset of adverse effects.
  • Measures effective dose (ED50) and toxic concentrations from the PK profile.

Drug Development Process

Phases of Development:
  1. Discovery Phase:
       - Thousands of compounds evaluated for potential drug candidates.
  2. Preclinical Testing:
       - Testing in vitro (cell culture) and in vivo (animal models) to assess pharmacokinetics, safety.
  3. Phase 1 Trials:
       - First introduction to humans; focuses on safety, tolerability, pharmacokinetics, and pharmacodynamics through various dosing regimens.
  4. Phase 2 Trials:
       - Explores efficacy in a larger patient population, determining the optimal dose for therapeutic effect versus safety.
  5. Phase 3 Trials:
       - Large-scale studies involving thousands of patients to confirm safety and efficacy prior to regulatory submission.
Regulatory Review:
  • After successful phase 3 completion, the data package is submitted for regulatory approval (NDA for small molecules, BLA for biologics).
  • The review involves rigorous questioning and critical evaluation of data by regulatory agencies.

Key Studies in Clinical Pharmacology

  • Bioavailability Studies: Understand the percentage of a drug absorbed into systemic circulation.
  • Food Effect Studies: Evaluate how food influences drug absorption and modify dosing instructions accordingly.
  • Drug Interaction Studies: Assess how commonly prescribed medications might affect the pharmacokinetics of the new drug.
  • QT Interval Studies: Determine if a drug influences cardiac rhythm and prolongs the QT interval, which can lead to serious arrhythmias.
  • Intrinsic and Extrinsic Factors Studies: Consider patient demographics, comorbidities, and medication history in pharmacokinetic and safety evaluations.

Impact of Clinical Pharmacology

Career Paths:
  • Clinical pharmacologists may work in various settings:
      - Pharmaceutical companies
      - Academic institutions
      - Regulatory agencies
      - Research institutions
Skill Sets Required:
  • Ability to analyze data across multiple disciplines and engage in collaborative teams.
  • Strong quantitative skills and a good understanding of mathematical modeling.
  • Effective communication skills to convey complex scientific information.
  • Critical thinking and strategic planning capabilities are crucial for success.
Importance of Multidisciplinary Integration:
  • Collaborate with toxicologists, chemists, manufacturing experts, and regulators to ensure comprehensive understanding and mutual validation of drug-related data.

Final Thoughts

  • Clinical pharmacology plays a profound role in improving drug development outcomes, directly serving patient health and safety.
  • Remains a critical strategic driver in defining dosages, minimizing risks, and enhancing rational drug utilization protocols.
  • Encouragement for aspiring clinical pharmacologists to engage actively and embrace the multidisciplinary nature of the field for personal and professional growth.